Alabama
Birmingham; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Tuscaloosa; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Arizona
Gilbert; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Litchfield Park; Dedicated Clinical Research
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Mesa; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Peoria; Pivotal Research Centers, LLC
Parkinson's Disease...Does your medicine stop working before your next dose is due?
Peoria; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Phoenix; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Scottsdale; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Sun City; Sun Health Research Institute
Phase II - Assessing the efficacy and safety of a new investigational drug when used together with a stable dose of L-dopa in the treatment of Parkinson's Disease
Sun City; Sun Health Research Institute
Phase II - Determining Mirapex ER efficacy, safety and tolerability in the treatment Parkinson's Disease
Sun City; Sun Health Research Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Arkansas
Little Rock; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
California
Fountain Valley; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Fresno; The Margolin Brain Institute
Parkinson’s Patients
Fresno; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
La Jolla; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Loma Linda; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Oxnard; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Oxnard; Pacific Neuroscience Medical Group
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Reseda; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Sunnyvale; The Parkinson's Institute
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Ventura; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Colorado
Aurora; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Englewood; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Connecticut
Danbury; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations.
New Haven; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Florida
Boca Raton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Bradenton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Bradenton; Bradenton Research
Have you been recently diagnosed with Parkinson's Disease?
Gainesville; Southeastern Integrated Medical
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Jacksonville; Mayo Jacksonville Department of Neurology
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Jacksonville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Miami; University of Miami Miller School of Medicine
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Miami; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Naples; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Ocala; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Pompano Beach; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
St. Petersburg; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
St. Petersburg; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Sunrise; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Georgia
Atlanta; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Macon; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Suwanee; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Illinois
Chicago; Saint Mary of Nazareth Hospital Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
North Chicago; North Chicago VA Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Indiana
Elkhart; Indiana Medical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Iowa
Des Moines; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Kansas
Kansas City; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Kentucky
Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Parkinson’s Disease Research Study
Lexington; University of Kentucky Chandler Medical Center
Announcing a Research Study for Patients with Parkinson’s Disease
Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Research Study on Parkinson’s Disease
Louisville; University of Louisville
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Louisville; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Maryland
Baltimore; University of Maryland Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Massachusetts
Boston; Beth Israel Deaconess Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Boston; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Worcester; University of Massachusetts Worcester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Michigan
Southfield; Henry Ford Health System
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Southfield; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Minnesota
Golden Valley; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Rochester; Mayo Clinic Rochester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Missouri
St Louis; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Montana
Missoula; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Nebraska
Omaha; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Nevada
Henderson; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
New Jersey
Edison; JFK Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York
Brooklyn; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Commack; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Forest Hills; Biomedical Research Alliance of New York
Parkinson’s Disease with Motor Fluctuations - Adults
Forest Hills; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations
Manhasset; Biomedical Research Alliance of New York
A clinical study to test the safety, efficacy, and tolerability of an experimental drug in Parkinson’s Disease Patients with Motor Fluctuations
New York; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
New York; Biomedical Research Alliance of New York
Parkinson’s Disease- Adults
New York; Biomedical Research Alliance of New York
Tremor Supression
New York; Biomedical Research Alliance of New York
Parkinson's Disease - Deep Brain Stimulation
New York; Biomedical Research Alliance of New York
Parkinson's Disease
New York; Mount Sinai Medical Center
Parkinson Disease Collaborative Study of Genetic Linkage
New York City; NYU Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
New York City; Columbia University Neurological Institute of NY
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; University of Rochester
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Rochester; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
North Carolina
Raleigh; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Salisbury; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Salisbury; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Salisbury; Central Carolina Neurology & Sleep, PA
24-Hour Treatment for Parkinson's Patient
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Ohio
Canton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Cleveland; University Hospitals Case Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Cleveland; Cleveland Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Columbus; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Toledo; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Oklahoma
Oklahoma City; COR Clinical Research, LLC
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Pennsylvania
Greensburg; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Souderton; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Upland; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Rhode Island
Warwick; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Tennessee
Memphis; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Nashville; Vanderbilt University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Texas
Dallas; UT Southwestern Medical Center
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Dallas; Radiant Research - Dallas North
Parkinson’s Research
Lubbock; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
San Antonio; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
San Antonio; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Utah
Bountiful; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Midvale; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Midvale; Pivotal Research Centers, LLC
Parkinson's Disease? Does your medicine stop working before your next dose is due?
Vermont
Burlington; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Virginia
Charlottesville; University of Virginia
UVa Health System, Department of Neurology, seeks Woman and Men with Parkinsons Disease for research study.
Richmond; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Roanoke; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Washington
Kirkland; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Spokane; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Various Cities; Research Center
Parkinson's Disease Dementia Study CENA713B2315
Washington, DC
Various Cities; Research Center
Parkinson's Disease Study CELC200AUS14
West Virginia
Morgantown; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Wisconsin
Milwaukee; UCB Clinical Trial Call Center
Trial to Assess PD Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
International
Adelaide, South Australia, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Concord, New South Wales, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Fitzroy, Australia; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Innsbruck, Austria; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Hamilton, Ontario, Canada; McMaster University
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Markham, Ontario, Canada; Centre for Movement Disorders
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Montreal, Quebec, Canada; SMBD Jewish General Hospital
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Ottawa, Ontario, Canada; Parkinson's & Neurodegenerative Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Quebec City, Quebec, Canada; Quebec Memory and Motor Skills Disorders Clinic
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Oulu, Finland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Kassel, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Naumburg, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Ulm, Germany; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Debrecen, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Nyiregyhaza, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Pécs, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Zalaegerszeg, Hungary; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Milano, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Torino, Italy; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Gdansk, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Krakow, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lublin, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Olsztyn, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa, Poland; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Cape Town, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Johannesburg, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Pretoria/Gauteng, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Tygerberg, South Africa; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Barcelona, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Madrid, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Madrid, Spain; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Bristol, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lancashire, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Liverpool, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
London, United Kingdom; UCB Clinical Trial Call Center
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
